Maxim Positive on ContraVir Pharma (CTRV) Following CMX157 Phase 2a Update
Go back to Maxim Positive on ContraVir Pharma (CTRV) Following CMX157 Phase 2a Update| Contravir Pharmaceuticals, Inc. (NASDAQ: CTRV) | Delayed: 3.58 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $3.58 | 52 Week High | $2.65 | |||
| Open | $8.22 | 52 Week Low | $0.76 | |||
| Day High | $3.58 | P/E | N/A | |||
| Day Low | $3.58 | EPS | $0.00 | |||
| Volume | 16,101 | |||||
| OncoGenex Pharmaceuticals, Inc. (NASDAQ: OGXI) | Delayed: 0.40 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $0.40 | 52 Week High | $2.80 | |||
| Open | $0.05 | 52 Week Low | $0.33 | |||
| Day High | $0.40 | P/E | N/A | |||
| Day Low | $0.40 | EPS | $-1.98 | |||
| Volume | 500 | |||||
